237 related articles for article (PubMed ID: 17222299)
1. Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.
Niamba P; Goumbri-Lompo O; Traoré A; Barro-Traoré F; Soudré RT
Australas J Dermatol; 2007 Feb; 48(1):32-4. PubMed ID: 17222299
[TBL] [Abstract][Full Text] [Related]
2. Disseminated cutaneous leishmaniasis.
Sharquie KE; Najim RA
Saudi Med J; 2004 Jul; 25(7):951-4. PubMed ID: 15235707
[TBL] [Abstract][Full Text] [Related]
3. [Sporotrichoid cutaneous leishmaniasis].
López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
[No Abstract] [Full Text] [Related]
4. Unusual form of cutaneous leishmaniasis: erysipeloid form.
Mnejja M; Hammami B; Chakroun A; Achour I; Charfeddine I; Chakroun A; Turki H; Ghorbel A
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):95-7. PubMed ID: 21251895
[TBL] [Abstract][Full Text] [Related]
5. Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
Yébenes M; Cruz I; Cañavate C; Gilaberte M; Baena V; Pujol RM
Clin Exp Dermatol; 2008 Mar; 33(2):142-4. PubMed ID: 18076691
[TBL] [Abstract][Full Text] [Related]
6. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
8. Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B.
Morrison B; Mendoza I; Delgado D; Reyes Jaimes O; Aranzazu N; Paniz Mondolfi AE
Clin Exp Dermatol; 2010 Jun; 35(4):e116-9. PubMed ID: 19886959
[TBL] [Abstract][Full Text] [Related]
9. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
10. Post-kala-azar dermal leishmaniasis.
Baghestani S; Handjani F; Sodeifi M; Kumar PV
Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
[TBL] [Abstract][Full Text] [Related]
11. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
Salmanpour R; Razmavar MR; Abtahi N
Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
[No Abstract] [Full Text] [Related]
13. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
Masood S; Naveed S; Alvi RU
Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupoid leishmaniasis: a case report.
Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
[TBL] [Abstract][Full Text] [Related]
15. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
[TBL] [Abstract][Full Text] [Related]
16. [Diffuse cutaneous leishmaniasis in a patient with AIDS].
Pérez C; Solías Y; Rodríguez G
Biomedica; 2006 Dec; 26(4):485-97. PubMed ID: 17315475
[TBL] [Abstract][Full Text] [Related]
17. [Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis].
Lenvers P; Marty P; Peyron F
Ann Dermatol Venereol; 2013 Nov; 140(11):704-7. PubMed ID: 24206806
[TBL] [Abstract][Full Text] [Related]
18. Drug hypersensitivity syndrome induced by meglumine antimoniate.
Jeddi F; Caumes E; Thellier M; Jauréguiberry S; Mazier D; Buffet PA
Am J Trop Med Hyg; 2009 Jun; 80(6):939-40. PubMed ID: 19478253
[TBL] [Abstract][Full Text] [Related]
19. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
Noguera-Morel L; Azorin D; Xirotagaros G
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Krolewiecki AJ; Romero HD; Cajal SP; Abraham D; Mimori T; Matsumoto T; Juarez M; Taranto NJ
Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
